×
We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.09 | 84.8 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| Bajaj Healthcare Limited | 1497.14 | 118.34 | 1488.36 | 3.75 | 1,492 | 31.7 |
| Sigachi Industries Limited | 1149.17 | -991.45 | 1109.77 | -2.59 | 1455 | 19.1 |
| JAGSONPAL PHARMACEUTICALS LTD. | 784.37 | 107.95 | 756.12 | 1.58 | 1432 | 33.6 |
Bajaj Healthcare Limited, with Security Code 539872, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 158.4 | 129.7 | 101.2 | 108.6 | 133.9 | 132.2 | 133.1 | 122.8 | 154.5 | 148.8 |
| Expenses | 139.4 | 108.0 | 82.3 | 89.0 | 117.9 | 107.7 | 108.6 | 101.2 | 142.7 | 124.3 |
| Operating Profit | 19.1 | 21.7 | 19.0 | 19.5 | 16.0 | 24.5 | 24.5 | 21.6 | 11.8 | 24.5 |
| OPM % | 12.03% | 16.76% | 18.72% | 17.99% | 11.97% | 18.53% | 18.43% | 17.62% | 7.63% | 16.47% |
| Other Income | 0.7 | 0.2 | 1.2 | 0.8 | -37.9 | 0.9 | 2.6 | 2.4 | 13.6 | 0.9 |
| Interest | 7.4 | 8.8 | 8.3 | 6.7 | 6.0 | 8.4 | 7.9 | 5.5 | 6.1 | 5.2 |
| Depreciation | 7.4 | 6.3 | 6.7 | 7.4 | 7.3 | 6.7 | 6.8 | 6.9 | 7.5 | 5.6 |
| Profit before tax | 5.0 | 6.9 | 5.2 | 6.3 | 9.2 | 10.2 | 12.4 | 11.7 | 11.7 | 14.5 |
| Tax % | -28.2% | 1.8% | -2.3% | -12.7% | -9% | 21.2% | 33% | -28.4% | -0.9% | 16.2% |
| Net Profit | 3.6 | -48.2 | -3.5 | -2.2 | -29.9 | 7.1 | 9.5 | 11.7 | 11.2 | 11.8 |
| EPS in Rs | 1.3 | -17.46 | -1.25 | -0.8 | -10.84 | 2.59 | 3.36 | 3.64 | 0.13 | 3.64 |
No Consolidated data available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 5% |
| 3 Years: | -10% |
| TTM: | 6% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 51% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 35% |
| 3 Years: | 22% |
| 1 Year: | 91% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| News Date ▲▼ | Headline ▲▼ | Issuer Entity ▲▼ | Issuer Type ▲▼ | Order Size ▲▼ | Time Period ▲▼ | |
|---|---|---|---|---|---|---|
| Loading company updates… | ||||||
We couldn’t find any filings or updates in the Company News collection for this BSE code.
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|